Back
22nd Century Group Vs. BioNTech SE Industry Stock Comparison
Sell
29
XXII
22nd Century Group
Last Price:
$5.73
Seasonality Move:
-4.25%
Buy
52
BNTX
BioNTech SE
Last Price:
$117.19
Seasonality Move:
4.91%
Sell
29
22nd Century Group (XXII)
is a Sell
Is 22nd Century Group a Buy, Sell or Hold?
-
The current 22nd Century Group [XXII] share price is $5.10. The Score for XXII is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
XXII is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
BioNTech SE (BNTX)
is a Buy
Is BioNTech SE a Buy, Sell or Hold?
-
The current BioNTech SE [BNTX] share price is $117.25. The Score for BNTX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
BNTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XXII Stock Price Chart
What is 22nd Century Group's stock price today?
-
The 22nd Century Group share price today is $5.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XXII is experiencing slight buying pressure.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $117.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BNTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
XXII Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1 | Sell |
Relative Strength Index (14 RSI): | 41.18 | Sell |
Chaikin Money Flow: | -620478 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BNTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 52.32 | Buy |
Chaikin Money Flow: | 468042 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.8 - 119.84) | Buy |
Bollinger Bands (100): | (102.74 - 121.44) | Buy |
XXII Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.26 | Sell |
20-day SMA: | 5.72 | Sell |
50-day SMA: | 9.61 | Sell |
200-day SMA: | 83.1 | Sell |
8-day EMA: | 6.08 | Sell |
20-day EMA: | 6.57 | Sell |
50-day EMA: | 11.39 | Sell |
200-day EMA: | 801.41 | Sell |
BNTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 115.85 | Buy |
20-day SMA: | 115.56 | Buy |
50-day SMA: | 114.12 | Buy |
200-day SMA: | 100.26 | Buy |
8-day EMA: | 115.34 | Buy |
20-day EMA: | 115.79 | Buy |
50-day EMA: | 114.48 | Buy |
200-day EMA: | 106.02 | Buy |
22nd Century Group Earnings Growth & XXII Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and a decrease next year of $0.00 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.12 per share.
22nd Century Group Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BioNTech SE Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |